Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1893 of 6351
-
School equity program aims to curb youth violence and suicide
Prevention By invitation onlyInterpersonal or community violence is a long-standing health disparity that disproportionately affects African American youth, and suicide is disproportionately increasing among African American youth. This project evaluates the impact of a multisystemic prevention program desig…
Sponsor: University of South Alabama • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Could tailored blood thinner dosing prevent strokes in chinese patients?
Knowledge-focused Recruiting nowDirect oral anticoagulants (DOACs) have emerged as safe and efficacious ischemic stroke prophylaxis for non-valvular atrial fibrillation (NVAF). All four DOACs - apixaban, dabigatran, edoxaban, and rivaroxaban - were shown to reduce the risk of major bleeding compared to warfarin…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Gene test may cut chemo harm in pancreatic and colon cancer
Disease control Recruiting nowThis is a prospective, randomized study designed to compare genotype-guided dosing to usual care in patients with pancreas cancer and colorectal cancer who are UGT1A1 intermediate metabolizers (\*1/\*28) (heterozygotes) and usual UGT metabolizers (\*1/\*1). All patients will be a…
Sponsor: Reema A. Patel • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could dupilumab help Hard-to-Treat asthma patients?
Disease control CompletedIt has been observed that certain section of patients having severe to moderate Asthma, do not benefit from oral corticosteroids and IL-5 blocking biologics. There is increasing evidence that Airway auto immunity may be responsible for this poor response to treatment. It has been…
Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Gene-Guided cancer therapy: a new hope for advanced tumors?
Knowledge-focused Recruiting nowA national, prospective, multi-center, open-label, multi-cohort study comprised of a framework to screen patients for actionable targets and evaluation of molecular profiling guided therapy recommended by MTB based on genomic alterations using targeted and/or immunotherapies outs…
Sponsor: Seoul National University Bundang Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New combo inhaler aims to stop asthma attacks faster
Disease control CompletedA study evaluating efficacy and safety of repeated doses of PT027 compared to PT007 in patients with asthma and acute airway obstruction induced by repeated mannitol challenges
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug ABC008 tested for rare blood cancer
Disease control CompletedAn open label, ascending dose study for adult subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Phase 1/2 • Sponsor: Abcuro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New scan could catch lung disease before symptoms start
Diagnosis Recruiting nowThe goal of this study is to investigate the ability of \[68Ga\]CBP8 to detect collagen deposition in early interstitial lung disease.
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
Can a peptide tame type 1 diabetes?
Disease control CompletedPhase 1b designed to assess safety, pharmacokinetics, immunological and clinical effects of multiple ascending doses of OPT101.
Phase 1 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a shorter TB drug combo beat Drug-Resistant TB?
Disease control CompletedThe purpose of the study was to evaluate the efficacy (how well the medicines work) and tolerability (whether participants stop treatment because of side effects from a drug) of an anti-TB treatment regimen that compared two doses of linezolid (LZD), combined with bedaquiline (BD…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New Diamond-Tipped catheter takes on heart rhythm disorder
Disease control CompletedVentricular Tachycardia (VT) is a life threatening heart rhythm that comes from the bottom chambers of the heart (the ventricles) and is a leading cause of sudden cardiac death. The majority of patients that are at risk of VT or suffer a cardiac arrest will have an Internal Card…
Sponsor: University Hospitals Coventry and Warwickshire NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New 'Four-in-One' antibody takes on Hard-to-Treat lymphoma
Disease control Recruiting nowTo explore the safety and preliminary efficacy of GNC-038 in patients with relapsed or refractory NHL, and to determine the MTD and RP2D of GNC-038, or the MAD and DLT
Phase 1/2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Virtual heart map may improve ablation for dangerous heart rhythms
Disease control CompletedThe goal of this study is to test the efficacy of the new imaging/simulation ("virtual heart") approach for determining the optimal ablation sites in patients with VT, which render post-infarction VT non-inducible. The study will test both the acute outcome of the ablation proced…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Real-World data shows promise for kidney cancer drug combo
Disease control CompletedThe purpose of this study is to collect data to describe the safety and effectiveness of cabozantinib and nivolumab in combination as a first-line treatment in adults with aRCC with clear cell-component, according to real-world clinical practice. The decision to prescribe cabozan…
Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New heart procedure could be safer and just as effective for AFib
Disease control OngoingPulmonary vein isolation (PVI) is an effective treatment for atrial fibrillation (AF). Currently, Medtronic Arctic Front Cryoballoon is the most frequently used single shot technology and hence is the benchmark for upcoming technologies. A novel method, pulse-field ablation (PFA)…
Phase 4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Virtual reality may ease pain of egg retrieval without extra drugs
Symptom relief CompletedMedically Assisted Reproduction provides help to infertile couples, single women and couples of women with a pregnancy project, and to women who wish to preserve their gametes. In the context of In Vitro Fertilization (IVF), oocyte donation or oocyte preservation, it is necessary…
Sponsor: Rennes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Fish oil and remote rehab: a new hope for long COVID sufferers?
Disease control CompletedSARS-CoV-2 is the coronavirus responsible for developing the disease known as COVID-19. Once the acute phase of the disease has passed, about 40% of the people who discharged continue to have symptoms, and of these, between 50 and 70% present them up to three months later. These …
Sponsor: Instituto de Investigación Sanitaria Aragón • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could HPV shots start earlier? study tests vaccine in kids as young as 4
Vaccine OngoingThis study is an open-label nonrandomized exploratory proof of concept and descriptive 4-year immunogenicity study to assess immunogenicity after administration of a 2-dose regimen of 9-valent human papillomavirus vaccine (9vHPV) vaccine separated by 12 months (months 0, 12).
Early phase 1 • Sponsor: Boston Medical Center • Aim: Vaccine
Last updated Jul 03, 2026 00:00 UTC
-
New drug cocktail shows promise for rare eye cancer that spreads to liver
Disease control CompletedSITISVEAL stablish the hypothesis that treatment with Tislelizumab + Sitravatinib will increase the Objective Response Rate in patients with Metastatic Uveal Melanoma with liver metastases, compared with the current standard of care. This is a non-randomized, single arm, multice…
Phase 2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a brief home therapy cut suicide reattempts? new study aims to find out
Disease control OngoingThe present study consists of 3 projects in total. It aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the feasibility and cost-effectiveness of ASSIP flex. The overall aim of Project 3 is to evaluate the feasibility …
Sponsor: University of Bern • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC